EXoPERT EMERALD Clinical Study

Exclusion Criteria

• •Any history of cancer diagnosed and treated within 5 years prior to the date of consent.
• •Subjects with a history of previous cancer treatment via surgical resection, hormonal cancer treatment, chemotherapy, radiotherapy within the past 6 months for recent cancer diagnosis.
• •Subjects who have any history of an allogeneic bone marrow, stem cell transplant, or solid organ transplant.
• •Subjects who are pregnant or breastfeeding women.
• •Subjects who have consented and have undergone treatment in any other cancer related clinical trials withinthe past 6 months.
• •Subjects who are currently in active treatment for drug abuse.
• •Subjects who have received any treatment related to lung, breast, colorectal, pancreatic, or ovarian nodules, such as hormones prior to entering the study.
• •Unsuitable sample for testing due to contamination, hemolysis, etc.